Analysis of the role of behavioural factors in the development of tolerance to the benzodiazepine midazolam
- PMID: 3587532
- DOI: 10.1016/0028-3908(87)90210-3
Analysis of the role of behavioural factors in the development of tolerance to the benzodiazepine midazolam
Abstract
Two experiments were conducted on the acute and chronic effects of the short-acting benzodiazepine midazolam on fixed ratio schedule-maintained operant responding in rats. Acute administration of midazolam produced suppression of responding in large doses but elevation of responding in small doses. Following intermittent (every third day) chronic treatment tolerance developed rapidly to the rate-suppressant effects of large doses of midazolam but did not develop to the rate-elevating effects of small doses, even after chronic treatment with large doses of the drug. Thus, when tolerance was measured in terms of shifts in dose-effect curves, it was manifested as a non-parallel shift in the curve after chronic treatment. Since tolerance developed to the effects of large but not small doses, the observed tolerance could not be attributed to changes in disposition of the drug. The development of tolerance did not depend on whether the drug was given before or after behavioural testing. These findings contrast with data reported in behavioural studies with other sedative-hypnotics (ethanol, barbiturates). Animals tolerant to midazolam showed no cross-tolerance to ethanol, a drug for which there is reliable evidence indicating that behavioural factors play a role in acquisition of tolerance. Tolerance to midazolam cannot therefore be explained in terms of learned strategies acquired as a result of drug-induced loss of rewarding stimuli. This conclusion contrasts with recent suggestions (File, 1985; File and Pellow, 1985) that tolerance to benzodiazepines may be mediated by instrumental conditioning processes.
Similar articles
-
Investigation of the development of tolerance to the actions of zolpidem and midazolam.Neuropharmacology. 1987 Oct;26(10):1513-8. doi: 10.1016/0028-3908(87)90172-9. Neuropharmacology. 1987. PMID: 3683765
-
Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnil.Pharmacol Biochem Behav. 1995 Jun-Jul;51(2-3):481-90. doi: 10.1016/0091-3057(95)00014-n. Pharmacol Biochem Behav. 1995. PMID: 7667373
-
Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat.Br J Pharmacol. 1979 Feb;65(2):183-92. doi: 10.1111/j.1476-5381.1979.tb07817.x. Br J Pharmacol. 1979. PMID: 760896 Free PMC article.
-
Analysis of the role of drug-predictive environmental stimuli in tolerance to the hypothermic effects of the benzodiazepine midazolam.Psychopharmacology (Berl). 1986;90(4):513-21. doi: 10.1007/BF00174071. Psychopharmacology (Berl). 1986. PMID: 3101106
-
Tolerance to the behavioral actions of benzodiazepines.Neurosci Biobehav Rev. 1985 Spring;9(1):113-21. doi: 10.1016/0149-7634(85)90037-5. Neurosci Biobehav Rev. 1985. PMID: 2858076 Review.
Cited by
-
Tolerance, cross-tolerance and dependence measured by operant responding in rats treated with triazolam via osmotic pumps.Psychopharmacology (Berl). 1994 Jun;115(1-2):86-94. doi: 10.1007/BF02244756. Psychopharmacology (Berl). 1994. PMID: 7862917
-
Learnt tolerance to sedative effects of chlordiazepoxide on self-stimulation performance, but no tolerance to facilitatory effects after 80 days.Psychopharmacology (Berl). 1987;93(2):214-7. doi: 10.1007/BF00179936. Psychopharmacology (Berl). 1987. PMID: 3122253
-
Behavioural influences on benzodiazepine tolerance: when do they occur and what do they mean?Psychopharmacology (Berl). 1988;95(4):546-9. doi: 10.1007/BF00172972. Psychopharmacology (Berl). 1988. PMID: 2905504 No abstract available.
-
Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.Psychopharmacology (Berl). 1989;98(1):1-19. doi: 10.1007/BF00442000. Psychopharmacology (Berl). 1989. PMID: 2498952 No abstract available.
-
Reversal of overshadowing in a drug mixture discrimination in rats.Psychopharmacology (Berl). 1996 Jan;123(1):46-54. doi: 10.1007/BF02246280. Psychopharmacology (Berl). 1996. PMID: 8741954